Peutz–Jeghers syndrome: a systematic review and recommendations for management
- A D Beggs1,
- A R Latchford2,
- H F A Vasen3,
- G Moslein4,
- A Alonso5,
- S Aretz6,
- L Bertario7,
- I Blanco8,
- S Bülow9,
- J Burn10,
- G Capella11,
- C Colas12,
- W Friedl6,
- P Møller13,
- F J Hes14,
- H Järvinen15,
- J-P Mecklin16,
- F M Nagengast17,
- Y Parc18,
- R K S Phillips19,
- W Hyer19,
- M Ponz de Leon20,
- L Renkonen-Sinisalo15,
- J R Sampson21,
- A Stormorken22,
- S Tejpar23,
- H J W Thomas24,
- J T Wijnen14,
- S K Clark19,
- S V Hodgson1
- 1Department of Clinical Genetics, St George's Hospital, London, UK
- 2Department of Gastroenterology, Derriford Hospital, University of Plymouth, Devon, UK
- 3Department of Gastroenterology and Hepatology, Leiden University Medical Centre, Leiden, The Netherlands
- 4Department of Surgery, St Josefs Hospital Bochum-Linden (Helios), Bochum, Germany
- 5Department of Medical Genetics, Hospital Virgen del Camino, Pamplona, Spain
- 6Institute of Human Genetics, University of Bonn, Germany
- 7Department of Surgery, Hospital Tumori, Milan, Italy
- 8Genetic Counselling Unit, Prevention and Cancer Control Department, Catalan Institute of Oncology, Barcelona, Spain
- 9Danish Polyposis Registry, Department of Surgery, Hvidovre University Hospital, Hvidovre, Denmark
- 10Institute of Human Genetics, Newcastle-upon-Tyne, UK
- 11Institute Catala D'Oncologia, Barcelona, Spain
- 12Laboratoire d'Oncogenetique, Groupe Hospitalier Pitié-Salpêtre, Paris
- 13Section of Inherited Cancer, Department of Medical Genetics, Rikshospitalet-Radium Hospitalet Medical Centre, Oslo, Norway
- 14Departments of Human & Clinical Genetics, Leiden University Medical Centre, The Netherlands
- 15Department of Surgery, Helsinki University Central Hospital, Helsinki, Finland
- 16Department of Surgery, Jyvaskyla Central Hospital, Jyvaskyla, Finland
- 17Department of Gastroenterology and Hepatology, Radboud University Medical Centre, Nijmegen, The Netherlands
- 18Department of Digestive Surgery, Hospital Saint-Antoine, University Pierre et Marie, Paris, France
- 19The Polyposis Registry, St Mark's Hospital, Harrow, Middlesex, UK
- 20Department of Internal Medicine, University Hospital, Modena, Italy
- 21Institute of Medical Genetics, School of Medicine, Cardiff University, UK
- 22Department of Medical Genetics, Ullevål University Hospital, Oslo, Norway
- 23Digestive Oncology Unit, Department of Internal Medicine, University Hospital Gasthuisberg, Leuven, Belgium
- 24CRUK, Family Cancer Group, St Mark's Hospital, Harrow, Middlesex, UK
- Correspondence to Professor Shirley Hodgson, Department of Clinical Genetics, St Georges, University of London, Cranmer Terrace, London SW17 ORE, UK; shodgson{at}sgul.ac.uk
-
Contributors A Beggs and A Latchford contributed equally to the preparation of this manuscript.
- Revised 11 December 2009
- Accepted 16 December 2009
Abstract
Peutz–Jeghers syndrome (PJS, MIM175200) is an autosomal dominant condition defined by the development of characteristic polyps throughout the gastrointestinal tract and mucocutaneous pigmentation. The majority of patients that meet the clinical diagnostic criteria have a causative mutation in the STK11 gene, which is located at 19p13.3. The cancer risks in this condition are substantial, particularly for breast and gastrointestinal cancer, although ascertainment and publication bias may have led to overestimates in some publications. Current surveillance protocols are controversial and not evidence-based, due to the relative rarity of the condition. Initially, endoscopies are more likely to be done to detect polyps that may be a risk for future intussusception or obstruction rather than cancers, but surveillance for the various cancers for which these patients are susceptible is an important part of their later management.
This review assesses the current literature on the clinical features and management of the condition, genotype–phenotype studies, and suggested guidelines for surveillance and management of individuals with PJS. The proposed guidelines contained in this article have been produced as a consensus statement on behalf of a group of European experts who met in Mallorca in 2007 and who have produced guidelines on the clinical management of Lynch syndrome and familial adenomatous polyposis.
Footnotes
-
Competing interests None.
-
Provenance and peer review Not commissioned; externally peer reviewed.








